|
Latest Paper:
J Org Chem. 2012 Feb 24;:
22364173
Laura Baldini,
Roberta Cacciapaglia,
Alessandro Casnati,
Luigi Mandolini,
Riccardo Salvio,
Francesco Sansone,
Rocco Ungaro
Calix[4]arene derivatives, blocked in the cone conformation and functionalized with two to four guanidinium units at the upper rim were synthesized and investigated as catalysts in the cleavage of the RNA model compound 2-hydroxypropyl p-nitrophenyl phosphate. When compared with the behavior of a monofunctional model compound, the catalytic superiority of the calix[4]arene derivatives points to a high level of cooperation between catalytic groups. Combination of acidity measurements with the pH dependence of catalytic rates unequivocally shows that a necessary requisite for effective catalysis is the simultaneous presence, on the same molecular framework, of a neutral guanidine acting as a general base, and a protonated guanidine acting as an electrophilic activator. The additional guanidinium (guanidine) group in the diprotonated (monoprotonated) trifunctional calix[4]arene acts as a more or less innocent spectator. This is not the case with the tetrasubstituted calix[4]arene, whose mono-, di-, and triprotonated forms are slightly less effective than the corresponding di- and triguanidinocalix[4]arene derivatives, most likely on account of a steric interference with HPNP caused by overcrowding.
Carlo Visco,
Francesco Maura,
Giacomo Tuana,
Luca Agnelli,
Marta Lionetti,
Sonia Fabris,
Elisabetta Novella,
Ilaria Giaretta,
Gianluigi Reda,
Wilma Barcellini,
Luca Baldini,
Antonino Neri,
Francesco Rodeghiero,
Agostino Cortelezzi
Department of Hematology, Ospedale San Bortolo, Vicenza, Milano, Italy.
PURPOSE To assess biologic features related to the development of immune thrombocytopenia (ITP) in patients with chronic lymphocytic leukemia (CLL). EXPERIMENTAL DESIGN We retrospectively analyzed 463 patients with CLL with available immunoglobulin heavy-chain variable (IGHV) gene status and B-cell receptor (BCR) configuration [heavy-chain complementary-determining region 3 (HCDR3)], of whom thirty-six developed ITP, according to previously defined criteria. Most of them had available cytogenetic analysis. RESULTS We observed a significant association between ITP occurrence and IGHV unmutated gene status (P < 0.0001), unfavorable cytogenetic lesions (P = 0.005), and stereotyped HCDR3 (P = 0.006). The more frequent stereotyped HCDR3 subsets were #1 (IGHV1-5-7/IGHD6-19/IGHJ4; 16 of 16 unmutated) and #7 (IGHV1-69 or IGHV3-30/IGHD3-3/IGHJ6; 13 of 13 unmutated), both being significantly more represented among patients developing ITP (P = 0.003 and P = 0.001, respectively). Moreover, restricting the analysis to unmutated patients, subset #7 confirmed its independent significant association with the occurrence of ITP (P = 0.013). Both unmutated IGHV mutational status, del(11)(q23) and stereotyped BCR were significantly associated with shorter time to ITP development (P < 0.0001, P = 0.02, and P = 0.005, respectively) than other patients. CONCLUSION Our data suggest that patients with CLL and peculiar BCR conformations are at higher risk of developing secondary ITP and that stereotyped BCR may be involved in the pathogenesis of this complication.
M Ackermann,
M Ajello,
A Allafort,
W B Atwood,
L Baldini,
G Barbiellini,
D Bastieri,
K Bechtol,
R Bellazzini,
B Berenji,
R D Blandford,
E D Bloom,
E Bonamente,
A W Borgland,
A Bouvier,
J Bregeon,
M Brigida,
P Bruel,
R Buehler,
S Buson,
G A Caliandro,
R A Cameron,
P A Caraveo,
J M Casandjian,
C Cecchi,
E Charles,
A Chekhtman,
C C Cheung,
J Chiang,
S Ciprini,
R Claus,
J Cohen-Tanugi,
J Conrad,
S Cutini,
A de Angelis,
F de Palma,
C D Dermer,
S W Digel,
E do Couto E Silva,
P S Drell,
A Drlica-Wagner,
C Favuzzi,
S J Fegan,
E C Ferrara,
W B Focke,
P Fortin,
Y Fukazawa,
S Funk,
P Fusco,
F Gargano,
D Gasparrini,
S Germani,
N Giglietto,
P Giommi,
F Giordano,
M Giroletti,
T Glanzman,
G Godfrey,
I A Grenier,
J E Grove,
S Guiriec,
M Gustafsson,
D Hadasch,
A K Harding,
M Hayashida,
R E Hughes,
G Jóhannesson,
A S Johnson,
T Kamae,
H Katagiri,
J Kataoka,
J Knödlseder,
M Kuss,
J Lande,
L Latronico,
M Lemoine-Goumard,
M Llena Garde,
F Longo,
F Loparco,
M N Lovellette,
P Lubrano,
G M Madejski,
M N Mazziotta,
J E McEnery,
P F Michelson,
W Mitthumsiri,
T Mizuno,
A A Moiseev,
C Monte,
M E Monzani,
A Morselli,
I V Moskalenko,
S Murgia,
T Nakamori,
P L Nolan,
J P Norris,
E Nuss,
M Ohno,
T Ohsugi,
A Okumura,
N Omodei,
E Orlando,
J F Ormes,
M Ozaki,
D Paneque,
D Parent,
M Pesce-Rollins,
M Pierbattista,
F Piron,
G Pivato,
T A Porter,
S Rainò,
R Rando,
M Razzano,
S Razzaque,
A Reimer,
O Reimer,
T Reposeur,
S Ritz,
R W Romani,
M Roth,
H F-W Sadrozinski,
C Sbarra,
T L Schalk,
C Sgrò,
E J Siskind,
G Spandre,
P Spinelli,
A W Strong,
H Takahashi,
T Takahashi,
T Tanaka,
J G Thayer,
J B Thayer,
L Tibaldo,
M Tinivella,
D F Torres,
G Tosti,
E Troja,
Y Uchiyama,
T L Usher,
J Vandenbroucke,
V Vasileiou,
G Vianello,
V Vitale,
A P Waite,
B L Winer,
K S Wood,
M Wood,
Z Yang,
S Zimmer
Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany. markus.ackermann@desy.de
We measured separate cosmic-ray electron and positron spectra with the Fermi Large Area Telescope. Because the instrument does not have an onboard magnet, we distinguish the two species by exploiting Earth's shadow, which is offset in opposite directions for opposite charges due to Earth's magnetic field. We estimate and subtract the cosmic-ray proton background using two different methods that produce consistent results. We report the electron-only spectrum, the positron-only spectrum, and the positron fraction between 20 and 200 GeV. We confirm that the fraction rises with energy in the 20-100 GeV range. The three new spectral points between 100 and 200 GeV are consistent with a fraction that is continuing to rise with energy.
M Ackermann,
M Ajello,
A Albert,
W B Atwood,
L Baldini,
J Ballet,
G Barbiellini,
D Bastieri,
K Bechtol,
R Bellazzini,
B Berenji,
R D Blandford,
E D Bloom,
E Bonamente,
A W Borgland,
J Bregeon,
M Brigida,
P Bruel,
R Buehler,
T H Burnett,
S Buson,
G A Caliandro,
R A Cameron,
B Cañadas,
P A Caraveo,
J M Casandjian,
C Cecchi,
E Charles,
A Chekhtman,
J Chiang,
S Ciprini,
R Claus,
J Cohen-Tanugi,
J Conrad,
S Cutini,
A de Angelis,
F de Palma,
C D Dermer,
S W Digel,
E do Couto E Silva,
P S Drell,
A Drlica-Wagner,
L Falletti,
C Favuzzi,
S J Fegan,
E C Ferrara,
Y Fukazawa,
S Funk,
P Fusco,
F Gargano,
D Gasparrini,
N Gehrels,
S Germani,
N Giglietto,
F Giordano,
M Giroletti,
T Glanzman,
G Godfrey,
I A Grenier,
S Guiriec,
M Gustafsson,
D Hadasch,
M Hayashida,
E Hays,
R E Hughes,
T E Jeltema,
G Jóhannesson,
R P Johnson,
A S Johnson,
T Kamae,
H Katagiri,
J Kataoka,
J Knödlseder,
M Kuss,
J Lande,
L Latronico,
A M Lionetto,
M Llena Garde,
F Longo,
F Loparco,
B Lott,
M N Lovellette,
P Lubrano,
G M Madejski,
M N Mazziotta,
J E McEnery,
J Mehault,
P F Michelson,
W Mitthumsiri,
T Mizuno,
C Monte,
M E Monzani,
A Morselli,
I V Moskalenko,
S Murgia,
M Naumann-Godo,
J P Norris,
E Nuss,
T Ohsugi,
A Okumura,
N Omodei,
E Orlando,
J F Ormes,
M Ozaki,
D Paneque,
D Parent,
M Pesce-Rollins,
M Pierbattista,
F Piron,
G Pivato,
T A Porter,
S Profumo,
S Rainò,
M Razzano,
A Reimer,
O Reimer,
S Ritz,
M Roth,
H F-W Sadrozinski,
C Sbarra,
J D Scargle,
T L Schalk,
C Sgrò,
E J Siskind,
G Spandre,
P Spinelli,
L Strigari,
D J Suson,
H Tajima,
H Takahashi,
T Tanaka,
J G Thayer,
J B Thayer,
D J Thompson,
L Tibaldo,
M Tinivella,
D F Torres,
E Troja,
Y Uchiyama,
J Vandenbroucke,
V Vasileiou,
G Vianello,
V Vitale,
A P Waite,
P Wang,
B L Winer,
K S Wood,
M Wood,
Z Yang,
S Zimmer,
M Kaplinghat,
G D Martinez
W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, California 94305, USA.
Satellite galaxies of the Milky Way are among the most promising targets for dark matter searches in gamma rays. We present a search for dark matter consisting of weakly interacting massive particles, applying a joint likelihood analysis to 10 satellite galaxies with 24 months of data of the Fermi Large Area Telescope. No dark matter signal is detected. Including the uncertainty in the dark matter distribution, robust upper limits are placed on dark matter annihilation cross sections. The 95% confidence level upper limits range from about 10^{-26} cm^{3} s^{-1} at 5 GeV to about 5×10^{-23} cm^{3} s^{-1} at 1 TeV, depending on the dark matter annihilation final state. For the first time, using gamma rays, we are able to rule out models with the most generic cross section (∼3×10^{-26} cm^{3} s^{-1} for a purely s-wave cross section), without assuming additional boost factors.
J Clin Oncol. 2011 Dec 27;:
22203764
Daniele Vincenti,
Nicola Orofino,
Andrea Ferrario,
Maria Goldaniga,
Francesca Rossi,
Barbara Olivero,
Luca Baldini
Fondazione Istituto di Ricovero e Cura a Carattere Scientifico-Cà Granda Ospedale Maggiore Policlinico, Università degli Studi, Milano, Italy.
Am J Hematol. 2011 Oct 14;:
22189759
Alessandro Corso,
Monica Galli,
Silvia Mangiacavalli,
Fausto Rossini,
Andrea Nozza,
Cristiana Pascutto,
Vittorio Montefusco,
Luca Baldini,
Anna Maria Cafro,
Claudia Crippa,
Mario Cazzola,
Paolo Corradini
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Università di Pavia, Pavia, Italy. a.corso@smatteo.pv.it.
Complete response (CR) is associated with better outcome in patients with multiple myeloma (MM) treated with autologous transplant even though the progression-free survival (PFS) can be very variable among patients with good response. No simple and reliable prognostic scoring system, able to predict the duration of response, are so far available. Aim of this study was to identify any correlation between baseline clinical findings, response after transplant and the length of PFS, and thus develop a prognostic model. The new prognostic model was developed in a learning cohort of 549 patients with MM transplanted in five Italian hospitals. The prognostic value of this new score was confirmed in a validation cohort of 276 distinct patients with MM transplanted in two different Italian hospital. Univariate and multivariate analyses were performed using Cox models. The most important independent baseline predictor of transplant outcome, together with response after transplant, was International Staging System (ISS). We thus incorporated response to transplant and baseline ISS in a new scoring system, named response-adjusted international scoring system (RaISS), that was able to classify patients in three risk groups (low, intermediate, high) with different probabilities of progression after transplant (median PFS 35.9-15.4 months). The prognostic value of this new score was confirmed in the validation cohort. In conclusion, RaISS is a new simple and easily available scoring system that, accurately defining the risk of progression, can allow to identify patients who could deserve further treatment after transplant (consolidation, maintenance). Am. J. Hematol. 2011. © 2011 Wiley Periodicals, Inc.
Cancer. 2011 Dec 16;:
22179904
Andrea Ferrario,
Alessandro Pulsoni,
Barbara Olivero,
Giuseppe Rossi,
Umberto Vitolo,
Alessandra Tedeschi,
Francesco Merli,
Luigi Rigacci,
Caterina Stelitano,
Maria Goldaniga,
Donato Mannina,
Pellegrino Musto,
Francesca Rossi,
Enrica Gamba,
Luca Baldini
Hematology Unit 1, IRCCS Foundation, Ca Granda Hospital "Maggiore Policlinico", Milan University of Milan, Milan, Italy.
BACKGROUND: Indolent nonfollicular non-Hodgkin B-cell lymphomas (INFLs) are clonal mature B-cell proliferations for which treatment has not been defined to date. METHODS: In this phase 2 study of patients with advanced INFL, the authors evaluated the efficacy and safety of first-line rituximab, fludarabine, and cyclophosphamide (FCR) as induction immunochemotherapy (rituximab 375 mg/m(2) intravenously on day 1 of each cycle and on days 1 and 14 of cycles 4 and 5; fludarabine 25 mg/m(2) intravenously on days 2-4, cyclophosphamide 250 mg/m(2) intravenously on Days 2-4) every 28 days for 6 cycles followed by a maintenance phase with 4 infusions of rituximab (375 mg/m(2) intravenously on day 1) every 2 months for responders. RESULTS: Forty-seven patients were enrolled. Among 46 evaluable patients (28 men; median age, 59 years), 19 were diagnosed with lymphoplasmacytic lymphoma, 21 were diagnosed with small lymphocytic lymphoma, and 6 were diagnosed with nodal marginal zone lymphoma. The overall response rate after maintenance was 89.1% with a 67.4% complete remission (CR) rate (CR/unconfirmed CR) and a 21.7% partial response rate. After a median follow-up of 40.9 months, the failure-free survival and progression-free survival rates both were 90.1%, and the overall survival rate was 97.4%. The main toxicity was hematologic, and related grade 3 and 4 neutropenia was observed in 55.3% of patients. CONCLUSIONS: FCR induction therapy followed by a short maintenance phase is a highly effective regimen with acceptable toxicity. Cancer 2012;. © 2011 American Cancer Society.
M Ackermann,
M Ajello,
A Allafort,
L Baldini,
J Ballet,
G Barbiellini,
D Bastieri,
A Belfiore,
R Bellazzini,
B Berenji,
R D Blandford,
E D Bloom,
E Bonamente,
A W Borgland,
E Bottacini,
M Brigida,
P Bruel,
R Buehler,
S Buson,
G A Caliandro,
R A Cameron,
P A Caraveo,
J M Casandjian,
C Cecchi,
A Chekhtman,
C C Cheung,
J Chiang,
S Ciprini,
R Claus,
J Cohen-Tanugi,
A de Angelis,
F de Palma,
C D Dermer,
E do Couto E Silva,
P S Drell,
D Dumora,
C Favuzzi,
S J Fegan,
W B Focke,
P Fortin,
Y Fukazawa,
P Fusco,
F Gargano,
S Germani,
N Giglietto,
F Giordano,
M Giroletti,
T Glanzman,
G Godfrey,
I A Grenier,
L Guillemot,
S Guiriec,
D Hadasch,
Y Hanabata,
A K Harding,
M Hayashida,
K Hayashi,
E Hays,
G Jóhannesson,
A S Johnson,
T Kamae,
H Katagiri,
J Kataoka,
M Kerr,
J Knödlseder,
M Kuss,
J Lande,
L Latronico,
S-H Lee,
F Longo,
F Loparco,
B Lott,
M N Lovellette,
P Lubrano,
P Martin,
M N Mazziotta,
J E McEnery,
J Mehault,
P F Michelson,
W Mitthumsiri,
T Mizuno,
C Monte,
M E Monzani,
A Morselli,
I V Moskalenko,
S Murgia,
M Naumann-Godo,
P L Nolan,
J P Norris,
E Nuss,
T Ohsugi,
A Okumura,
E Orlando,
J F Ormes,
M Ozaki,
D Paneque,
D Parent,
M Pesce-Rollins,
M Pierbattista,
F Piron,
M Pohl,
D Prokhorov,
S Rainò,
R Rando,
M Razzano,
T Reposeur,
S Ritz,
P M Saz Parkinson,
C Sgrò,
E J Siskind,
P D Smith,
P Spinelli,
A W Strong,
H Takahashi,
T Tanaka,
J G Thayer,
J B Thayer,
D J Thompson,
L Tibaldo,
D F Torres,
G Tosti,
A Tramacere,
E Troja,
Y Uchiyama,
J Vandenbroucke,
V Vasileiou,
G Vianello,
V Vitale,
A P Waite,
P Wang,
B L Winer,
K S Wood,
Z Yang,
S Zimmer,
S Bontemps
W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA.
The origin of Galactic cosmic rays is a century-long puzzle. Indirect evidence points to their acceleration by supernova shockwaves, but we know little of their escape from the shock and their evolution through the turbulent medium surrounding massive stars. Gamma rays can probe their spreading through the ambient gas and radiation fields. The Fermi Large Area Telescope (LAT) has observed the star-forming region of Cygnus X. The 1- to 100-gigaelectronvolt images reveal a 50-parsec-wide cocoon of freshly accelerated cosmic rays that flood the cavities carved by the stellar winds and ionization fronts from young stellar clusters. It provides an example to study the youth of cosmic rays in a superbubble environment before they merge into the older Galactic population.
Division of Infectious Diseases, Department of Health Care Quality, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. wbranche@bidmc.harvard.edu
BACKGROUND Staphylococcus aureus (SA) breast abscesses are a complication of the postpartum period. Risk factors for postpartum SA breast abscesses are poorly defined, and literature is conflicting. Whether risk factors for methicillin-resistant SA (MRSA) and methicillin-susceptible SA (MSSA) infections differ is unknown. We describe novel risk factors associated with postpartum breast abscesses and the changing epidemiology of this infection. METHODS We conducted a cohort study with a nested case-control study (n = 216) involving all patients with culture-confirmed SA breast abscess among >30 000 deliveries at our academic tertiary care center from 2003 through 2010. Data were collected from hospital databases and through abstraction from medical records. All SA cases were compared with both nested controls and full cohort controls. A subanalysis was completed to determine whether risk factors for MSSA and MRSA breast abscess differ. Univariate analysis was completed using Student's t test, Wilcoxon rank-sum test, and analysis of variance, as appropriate. A multivariable stepwise logistic regression was used to determine final adjusted results for both the case-control and the cohort analyses. RESULTS Fifty-four cases of culture-confirmed abscess were identified: 30 MRSA and 24 MSSA. Risk factors for postpartum SA breast abscess in multivariable analysis include in-hospital identification of a mother having difficulty breastfeeding (odds ratio, 5.00) and being a mother employed outside the home (odds ratio, 2.74). Risk factors did not differ between patients who developed MRSA and MSSA infections. CONCLUSIONS MRSA is an increasingly important pathogen in postpartum women; risk factors for postpartum SA breast abscess have not changed with the advent of community-associated MRSA.
Pediatrics. 2011 Oct 17;:
22007011
Departments of Neonatology.
Objective:Methicillin-resistant Staphylococcus aureus (MRSA) colonization in NICUs increases the risk of nosocomial infection. Network analysis provides tools to examine the interactions among patients and staff members that put patients at risk of colonization.Methods:Data from MRSA surveillance cultures were combined with patient room locations, nursing assignments, and sibship information to create patient- and unit-based networks. Multivariate models were constructed to quantify the risk of incident MRSA colonization as a function of exposure to MRSA-colonized infants in these networks.Results:A MRSA-negative infant in the NICU simultaneously with a MRSA-positive infant had higher odds of becoming colonized when the colonized infant was a sibling, compared with an unrelated patient (odds ratio: 8.8 [95% confidence interval [CI]: 5.3-14.8]). Although knowing that a patient was MRSA-positive and was placed on contact precautions reduced the overall odds of another patient becoming colonized by 35%(95% CI: 20%-47%), having a nurse in common with that patient still increased the odds of colonization by 43%(95% CI: 14%-80%). Normalized group degree centrality, a unitwide network measure of connectedness between colonized and uncolonized patients, was a significant predictor of incident MRSA cases (odds ratio: 18.1 [95% CI: 3.6-90.0]).Conclusions:Despite current infection-control strategies, patients remain at significant risk of MRSA colonization from MRSA-positive siblings and from other patients with whom they share nursing care. Strategies that minimize the frequency of staff members caring for both colonized and uncolonized infants may be beneficial in reducing the spread of MRSA colonization.
|
Polish News | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|